catridecacog sold brand name tretten us novothirteen class recombinant factor xiii asubunit based biopharmaceutical medicine indicated patients rare clotting disorder congenital factor xiii asubunit deficiency kind factor xiii deficiency medication prevents bleeding patients condition approved us food drug administration fda use us brought market novo drug article relating blood blood forming organs stub help wikipedia expanding ithttpsenwikipediaorgwikicatridecacog